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Abstract
Lipid accumulation in adipocytes reflects a balance between enzymatic pathways leading to the formation and breakdown
of esterified lipids, primarily triglycerides. This balance is extremely important, as both high and low lipid levels in
adipocytes can have deleterious consequences. The enzymes responsible for lipid synthesis and breakdown (lipogenesis
and lipolysis, respectively) are regulated through the coordinated actions of several transcription factors (TFs). In this study,
we examined the dynamics of several key transcription factors (TFs) - PPARc, C/EBPb, CREB, NFAT, FoxO1, and SREBP-1c -
during adipogenic differentiation (week 1) and ensuing lipid accumulation. The activation profiles of these TFs at different
times following induction of adipogenic differentiation were quantified using 3T3-L1 reporter cell lines constructed to
secrete the Gaussia luciferase enzyme upon binding of a TF to its DNA binding element. The dynamics of the TFs was also
modeled using a combination of logical gates and ordinary differential equations, where the logical gates were used to
explore different combinations of activating inputs for PPARc, C/EBPb, and SREBP-1c. Comparisons of the experimental
profiles and model simulations suggest that SREBP-1c could be independently activated by either insulin or PPARc, whereas
PPARc activation required both C/EBPb as well as a putative ligand. Parameter estimation and sensitivity analysis indicate
that feedback activation of SREBP-1c by PPARc is negligible in comparison to activation of SREBP-1c by insulin. On the other
hand, the production of an activating ligand could quantitatively contribute to a sustained elevation in PPARc activity.
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Introduction
With rising prevalence of obesity and related diseases, numerous
studies have investigated the mechanisms underlying the expan-
sion in body fat, i.e. white adipose tissue (WAT). The bulk of WAT
cellular mass comprises metabolically active lipid-laden white
adipocytes. In vivo, almost the entire adipocyte volume is filled by
a single large lipid droplet, which expands or shrinks depending on
the body’s energy balance. Chronic overfeeding can lead to
significant expansion of adipocyte volume, termed hypertrophy, to
accommodate the storage of excess nutrients as lipids. In adult
humans, the total number of mature adipocytes is thought to
remain constant, as does the rate of turnover [1,2]. Formation of
new adipocytes through the differentiation of locally resident pool
of precursor cells in the stromal fraction is essential for WAT
remodeling [3]. However, net expansion of adipose tissue cellular
mass is quantitatively driven by an increase in the size of mature
adipocytes, as hyperplastic growth via recruitment of precursor
cells increases the number of small, newly differentiated adipocytes
that have a much smaller volume of fat stored [4].
At the cellular level, the fat content in adipocytes reflects a
balance between enzymatic pathways leading to the formation and
breakdown of esterified lipids, primarily triglycerides. This balance
is extremely important, as both high and low lipid levels in
adipocytes have deleterious consequences. Excessive accumulation
of lipids, leading to cellular hypertrophy correlates strongly with
accumulation of pro-inflammatory immune cells in WAT, which
in turn underpins tissue insulin resistance and other metabolic
alterations associated with obesity-related metabolic diseases [5–
7]. Conversely, failure to sequester fatty acids in adipocytes due to
inadequate lipid storage capacity is also not desirable, as this can
lead to an elevation in circulating levels of free fatty acids and
ectopic storage in other organs such as the liver [8].
The enzymes responsible for lipid synthesis and breakdown
(lipogenesis and lipolysis, respectively) are regulated through the
coordinated actions of several transcription factors (TFs) [9,10]. In
vitro, stimulation of growth-arrested preadipocytes with adipo-
genic hormones leads to an increase in the gene expression of
CCAAT/enhancer binding proteins b (C/EBPb) and d (C/EBPd)
[11]. This is followed by an increase in the expression of two other
TFs, peroxisome proliferator activated receptor-c (PPARc) and
C/EBPa [12], which is thought to induce the enzymes that confer
the recognizable metabolic phenotypes of the differentiated
adipocyte [10,13]. Along with sterol regulatory element binding
protein-1c (SREBP-1c), PPARc directly regulates the expression of
several genes in lipogenesis [14,15] as well as a key lipase that is
transcriptionally regulated and specifically enriched in adipocytes
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(adipose triacylglycerol lipase, ATGL). Transcriptional regulation
of lipogenesis also involves the two C/EBP isoforms b and a,
which are sequentially activated during differentiation. A major
target of these two isoforms is the gene encoding diacylglycerol
acyltransferase 2 (DGAT2), which catalyzes the final esterification
step in triglyceride synthesis.
The aforementioned TFs play a central role in regulating the
adipocyte differentiation program, underscoring the complex
interrelationship between molecular processes governing the
formation and size expansion of adipocytes. In addition to C/
EBP and PPARc, several other TFs have been shown to impact
adipogenesis. In vitro studies indicate that cyclic AMP response
element binding protein (CREB) is another early transcriptional
regulator of the adipogenic differentiation program that likely acts
upstream of C/EBP. Increasing CREB activity through the
addition of dibutyryl cAMP can induce differentiation in the
absence of other conventional inducing agents, although this
requires a very high (mM) concentration [9]. It has been shown
SREBP-1c can enhance adipogenesis by increasing PPARc
expression [16]. Unlike CREB, however, SREBP-1c cannot
directly initiate adipogenesis [14], and appears to depend on
PPARc for its own activation. Two other TFs, nuclear factor of
activated T cells (NFAT) and forkhead transcription factor
(FoxO1), appear to also modulate the activity of C/EBP and/or
PPARc. NFAT was demonstrated to form a composite enhancer
complex with C/EBP and potentiate PPARc expression [17],
whereas FoxO1 has been shown to counter PPARc activation in
3T3-L1 adipocytes [18].
These and other studies have led to significant progress in
identifying the roles played by different TFs in regulating
adipogenesis, and in some cases establishing activation/inhibition
relationships between TFs. However, only limited data is available
on the dynamics of the TFs in intact cells, particularly as the
dynamics relate to the interaction between these regulatory
molecules. In the context of obesity, achieving a desirable
adipocyte phenotype, for example curbing lipid accumulation
while maintaining differentiated adipocyte function, will likely
require careful modulation of a regulatory network comprising
several TFs whose dynamic activity profiles are interdependent.
For example, the inhibition of PPARc in vivo reduced adipogen-
esis, which is an expected outcome based on the known role of this
TF in differentiation. However, this intervention also increased
insulin resistance, one of the chief complications of type-2 diabetes
mellitus [19].
Recently, Simicevic and coworkers reported on dynamic
changes in absolute copy numbers of PPARc and its co-receptor
RXRa during differentiation of 3T3-L1 preadipocytes [20]. The
authors formulated a quantitative model of PPARc-DNA binding
based on the copy number, local chromatin state and binding
energetics. However, this study did not consider contributions
from other TFs to the differentiation process. Another recent study
investigated genome-wide changes of chromatin structure that
accompany binding of TFs during differentiation of 3T3-L1
preadipocytes [21]. Using DNase I hypersensitive site analysis, this
study found that multiple TFs (C/EBPb, C/EBPd, Stat5a, RXR,
glucocorticoid receptor) cooperatively bind to the same site early
in adipogenesis. The study also found that a subset of early
remodeled C/EBPb and C/EBPd binding sites are occupied by
PPARc in the later stage of adipogenesis, suggesting a regulatory
role of C/EBPb and C/EBPd for PPARc binding. Taken
together, these findings clearly indicate that temporal regulation
of TF expression plays a critical role in adipocyte differentiation.
The goal of this study was to characterize the dynamics and
interactions of the aforementioned TFs in adipocytes. To this end,
we generated a separate (3T3-L1) cell line for each TF capable of
reporting on the activation of the TF using secreted luciferase. We
used these reporter cells to examine the TF dynamics both during
adipogenic differentiation (week 1) and ensuing growth in
adipocyte size due to lipid accumulation [22]. Our data show
that TF activity generally peaks within one to two days following
the induction of differentiation, and declines thereafter. The
exception is the activity profile for PPARc, which is characterized
by an elevated plateau that is sustained well into the second week
following adipogenic induction. To quantitatively analyze the
observed profiles, we constructed a small interaction network
involving a subset of the aforementioned TFs, namely CREB, C/
EBPb, PPARc, and SREBP-1c, based on activation relationships
reported in the published literature. The dynamics of this network
was modeled using a combination of logical gates and ordinary
differential equations. The model was trained and then evaluated
against TF activity time profile data collected using the reporter
cells. Model simulations and parameter sensitivity analysis suggest
that the sustained elevation in PPARc activity could reflect a
positive feedback loop, where the PPARc induces the production
of an activating ligand (or ligands) via the induction of another TF,
SREBP-1c.
Results
Generation of Gaussia luciferase reporter cell lines
tracking transcription factor activity
A panel of six transcription factors (TFs) (PPARc, SREBP-1c,
NFAT, CREB, C/EBPb and FoxO1) was chosen to develop a
regulatory network underlying adipocyte differentiation and lipid
loading. Reporter plasmids were developed as described in
Materials and Methods and validated by determining if activation
of a TF led to expression of the Gaussia luciferase gene from the
reporter plasmid. For the TFs CREB, SREBP-1c, NFAT, and
FoxO1, plasmids containing the full-length gene for each TF were
over-expressed in 293T/17 cells by transfection along with the
corresponding reporter plasmid. Figure 1A shows 5–30 fold
increase in luciferase activity when the TFs were overexpressed
for 48 h. The 3T3-L1 PPARc reporter cell line was validated by
transfecting the cells with a plasmid containing the PPARc full
length gene and activating the TF with 25 mM of a chemical
agonist, rosiglitazone (RGZ). Figure 1B shows that overexpression
of PPARc increases PPARc-driven luciferase activity by 1.3-fold,
and stimulation with RGZ resulted in a 1.5-fold increase in
luciferase activity. The C/EBPb reporter was validated by
stimulating 3T3-L1 preadipocyte C/EBPb reporter cells with the
cytokine oncostatin M (OSM), which resulted in a 1.7 fold increase
in C/EBPb-driven luciferase activity (Figure 1C). Together, these
results confirmed the ability of the developed reporter cell lines to
report activation of the different TFs.
Lentivirus-mediated integration of the reporter plasmids into
3T3-L1 preadipocytes did not affect the ability of the different
reporter cells to differentiate into adipocytes. Figures 2A & B show
representative transmitted light and red fluorescence images of the
PPARc reporter cell line after 19 days in culture, and clearly
demonstrate that adipocyte differentiation was not affected (i.e.,
reporter cells show comparable accumulation of lipid droplets and
cell morphology to 3T3-L1 adipocytes without the reporter
plasmid). Moreover, no differences in differentiation and lipid
loading were observed between the different reporter cell lines
(Figure S1). In addition, more than 90% of reporter cells
demonstrated RFP expression, and suggest proper integration of
the reporter DNA.
Adipocyte Transcription Factor Network
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Profiles of transcription factor activity during adipocyte
differentiation and enlargement
3T3-L1 preadipocyte reporter cells were differentiated into
adipocytes and the activity of each TF was monitored throughout
the differentiation and maturation process. The different TFs
demonstrated markedly different activation dynamics. As shown in
Figure 3 and Dataset S1, CREB reporter cells demonstrated a
pronounced 13-fold increase in normalized luciferase activity
(RLU/h/RFU) on day1 after addition of differentiation media.
However, this increase was transient as the normalized luciferase
activity rapidly decreased and returned to day 0 levels by day 7.
On the other hand, PPARc reporter cells demonstrated a 3-fold
increase in luciferase activity in the first 24 h after induction of
differentiation. However, unlike CREB, this increase was
sustained, as nearly 2-fold higher activation of PPARc was
observed until day 17 post-differentiation compared to that in
preadipocytes. This trend was especially noticeable beyond day 7
post-differentiation. C/EBPb, SREBP-1c, NFAT and FoxO1 all
demonstrated similar activation dynamics with maximum activa-
tion observed at day 1 until day 3, and gradually decreasing to
near-baseline values after day 5.
Figure 1. Validation of TF reporter constructs. (A) Foxo1, CREB,
SREBP-1c, and NFAT3 reporter plasmids were validated by co-
transfecting plasmids for constitutive expression of each TFs (pCMV5-
FLAG-FoxO1, pCMV-Sport6-CREB, pSV Sport SREBP-1c, pEGFP-C1
NFAT3) and corresponding reporter plasmids into 293T/17 cells, and
monitoring the TF-mediated Gaussia luciferase (Gluc) activity. A yellow
fluorescence protein expressing plasmid (pEYFP-N1) plasmid was co-
transfected with each reporter plasmid as a control. (B) The PPARc
reporter construct was verified by transfecting a plasmid containing the
PPARc gene was into 3T3-L1 PPARc reporter cells, and activating PPARc
with 25 mM of rosiglitazone (RGZ). (C) The C/EBPb reporter construct
was validated by activating C/EBPb in 3T3-L1 preadipocyte C/EBPb
reporter cells with the cytokine oncostatin M (OSM). Data represent
mean 6 SD. *: p,0.05.
doi:10.1371/journal.pone.0100177.g001
Figure 2. Representative images of PPARc reporter cells 19
days post-induction. Micrographs show (A) transmitted light and (B)
red fluorescence microscopy images. Scale bar = 50 mm. Images for
other TF (FoxO1, CREB, NFAT, SREBP-1c, C/EBPb) reporter cell lines at
the mature adipocyte state are available in Figure S1.
doi:10.1371/journal.pone.0100177.g002
Figure 3. TF activity profiles. Gluc activity, which is a measure of TF
binding activity, was measured every 24 h post-medium change
starting from day 0 when differentiation was induced to day 17. The
rate of Gluc activity (RLU/h) was normalized with relative fluorescence
units (RFU) measured at that time point. The fold change in the increase
rate of Gluc activity was determined by normalizing the RLU/h/RFU
value at each time point to the corresponding value at the start of
differentiation (i.e., day 0). Data are from two independent experiments
and represent mean 6 SD.
doi:10.1371/journal.pone.0100177.g003
Adipocyte Transcription Factor Network
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Dynamic model of transcription factor interactions
Based on literature reports, a network model was assembled
describing the interactions between TFs as well as their stimulation
by adipogenic hormones (Figure 4). Only a subset of the measured
TFs (CREB, C/EBPb, PPARc, and SREBP-1c) was considered,
as the interactions involving NFAT and FoxO1 were less clearly
documented in the published literature. Activation and decay of
TFs were modeled using ordinary differential equations (ODEs)
based on mass action kinetics (Table S1) or Hill equations (Table
S2). Different possibilities regarding co-activation of TFs by
upstream factors were modeled using logical AND/OR gates
(Table S3), resulting in 64 model variants (32 mass action and 32
Hill equation models) (Table S4). The models’ parameters (i.e.
kinetic constants) were fitted to the normalized activity profiles
(Figure 3) by minimizing the sum of squared residuals (SSR)
between the measured and model-calculated TF activity profiles.
The Hill equation models generally resulted in smaller SSR
compared to the mass action models. The SSR for the mass action
models ranged from 4.15 to 13.13 with a median of 7.47, whereas
the SSR for the Hill equation models ranged from 3.05 to 5.47
with a median of 3.72 (Figure S2). Visual inspection of the
simulated profiles corroborated the trends indicated by the SSR
values. The TF activity profiles generated by the best fitting Hill
equation models (Figure 5) showed smoother curves and more
closely approximated the experimental data compared to the mass
action models (Figure 6). Regardless of rank (based on SSR), The
Hill equation models calculated essentially identical profiles for the
TFs. In comparison, there were more noticeable differences
between profiles calculated by the mass action models.
While the SSR values and calculated profiles appeared to
suggest that the Hill equations provided the better model structure,
the adjusted R2 values of these models were noticeably smaller (by
16.9%) than the corresponding R2 values (Table 1). The relatively
large discrepancy in the two statistics indicated that the Hill
equation models over-fit the available data. In comparison, the
adjusted R2 values for the best fitting (top 8) mass action models
were only slightly less (by 2.7%) than the corresponding R2 values.
Eight of the 32 mass action models had adjusted R2 values greater
than 0.90. Therefore, further analysis to discriminate between
different model variants (AND/OR gate combinations) focused on
these top 8 mass action models.
Every top mass action model (Table 1) included an OR gate at
the SREBP-1c node (Table S3), indicating that insulin or PPARc
could independently activate this TF. The trend was less clear for
the PPARc node. At this node, half of the top 8 models combined
the inputs C/EBPb and ligand using an AND gate, whereas the
other half used an OR gate. At the C/EBPb node, 6 out of the top
8 models used an OR gate for the DEX input, including the best
fitting model (MA31). The gate combination of the remaining two
models, (CREB AND DEX) OR PPARc, also suggested that DEX
may not be a required factor for C/EBPb activation, provided
PPARc is active. Indeed, PPARc alone was sufficient to activate
C/EBPb in 4 out of the 8 models, with the other 4 models
requiring both CREB and PPARc in the absence of DEX. While
PPARc appeared to play an essential role in C/EBPb activation,
Figure 4. Schematic of TF network model. Arrows indicate direction of interaction. Model parameters labeling the dotted arrows (k2, k5, k8, and
k10) represent first-order decay rate constants for the TFs. The rate constants shown in the schematic refer to the mass action models. See text for
abbreviations.
doi:10.1371/journal.pone.0100177.g004
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the role of CREB was more ambiguous. This ambiguity may
reflect the limited specificity of the reporter construct used in this
study, which could not differentiate between different C/EBP
isoforms. As the reporter could respond to activation of C/EBPa,
-b, or -d, it is possible (even likely) that the TF data used to train
the models represent the aggregate responses of all three isoforms,
whereas only the -b isoform depends on CREB [23].
Evaluation of model fit
Qualitatively, the TF time profiles generated using the best
fitting mass action model (MA31) were largely consistent with the
measured data. The calculated profiles correctly ordered the peak
activities for the TFs, and showed a sustained elevation in PPARc
activity extending to day 11 post-induction. On the other hand,
there were differences in the shapes of the calculated profiles
compared to the trends implied by the measured data. To
characterize the differences, we utilized a bootstrapping method to
estimate the confidence intervals (CIs) for the parameters and
variables of the model.
From the parameter distributions (Figure 7) and CI shape
values (L) (Table S1), it can be seen that the model was nonlinear
with respect to the parameters, especially k5, k10, k12, and k13,
which had shape values 8.62, 3.72, 5.78, and 3.31, respectively.
The CI lengths suggested that most of the parameters were well
constrained. For 9 out of the 13 kinetic parameters, the CI lengths
were of the same order magnitude or smaller than the median
estimated parameter value (Table S1), ranging from 1022 to 100.
The most tightly constrained parameters (L,1022) related to C/
EBPb: k3 (activation of C/EBPb by CREB), k7 (activation of C/
EBPb by PPARc) and k5 (degradation constant for C/EBPb).
Larger CI lengths (on the order of 101), and thus greater
uncertainty, were calculated for the parameters characterizing
the activation of PPARc by C/EBPb (k6), induction of ligand
production by SREBP (k11), and degradation of PPARc (k8).
To investigate the consequences of parameter uncertainty on
the simulated profiles, 95% CIs were computed for the TFs and
ligand from their distributions obtained using the bootstrap
parameters. Approximately 25% of the measured data points
were outside the calculated CIs. Specific discrepancies between
simulated and experimental profiles could be noted by locating the
data points lying outside the confidence intervals (Figure 8). For
example, the simulated profile for C/EBPb (Figure 8B) showed an
Figure 5. Simulated activity profiles for (A) CREB, (B) C/EBP, (C) PPARc, and (D) SREBP-1c generated using the top five Hill equation
models. The model numbers are shown in the figure legend, listed in order of increasing sum of squared residuals (SSR). The measured data
(normalized mean Gluc activities, RFL/h/RLU) are shown as red dots. The specific combination of logic gates for these models can be determined from
Tables S3 and S4.
doi:10.1371/journal.pone.0100177.g005
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initially sharp rise until day 2, followed by a rapid decline, whereas
the measured profile showed a broader peak extending from day 1
to day 5. For SREBP-1c (Figure 8D), the simulated profile showed
a delay in the peak activity relative to the measured data. Overall,
the shape differences in the TF profiles reflected a sharper rise or
fall of the simulations relative to the measured data, presumably
due to the simplifying assumptions regarding the concentrations of
the hormones (DEX, IBMX, and insulin), which were modeled as
step inputs.
Parameter sensitivity
To assess the sensitivity of the model simulations to the
estimated parameter values, a series of numerical perturbation
experiments were performed. Each perturbation experiment
decreased/increased the value of a single parameter by a fixed
fraction (e.g. 15%) while keeping all other parameters constant,
and calculated the change in TF and ligand time profiles. Similar
to the CI calculations, the perturbation experiments used a
sampling based approach, resulting in a distribution of changes for
each model species. Statistically, one-sample t-tests performed on
the changes showed that every parameter had a significant (non-
zero) impact (p,0.05) on at least one model species when the
parameter was decreased (or increased) by 15%, with most
parameters significantly affecting multiple model species (Dataset
S2). To obtain a more detailed analysis, we calculated an average
perturbed time profile for each TF or ligand, and compared this
perturbed profile against the 95% CIs of the corresponding
unperturbed profile. Table 2 summarizes the results of this
analysis for the case when each parameter was decreased or
increased by 15% from its baseline (unperturbed) value. Based on
the fraction of perturbed data points that lie outside the CIs, the
ligand profile was the least sensitive across all parameters,
presumably due to the large uncertainly of this profile, which
was not experimentally measured in this study. The CREB profile
was also largely insensitive to small perturbations, with the
exception of values assigned to k1 and k2, which characterize
CREB activation by IBMX and turnover of the TF, respectively.
The other three model species all exhibited large sensitivities,
especially with respect to the degradation constant of PPARc (k8),
degradation constant of SREBP-1c (k10) and rate constant for
ligand synthesis (k11). Similar trends were obtained for larger
perturbations (Dataset S3).
Figure 6. Simulated activity profiles for (A) CREB, (B) C/EBP, (C) PPARc, and (D) SREBP-1c generated using the top five mass action
models. The model numbers are shown in the figure legend, listed in order of increasing sum of squared residuals (SSR). The measured data
(normalized mean Gluc activities, RFL/h/RLU) are shown as red dots. The specific combination of logic gates for these models can be determined from
Tables S3 and S4.
doi:10.1371/journal.pone.0100177.g006
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Perturbation of the transcription factor network by
forskolin treatment
In order to evaluate the model with a new dataset, we
experimentally perturbed the TF network using forskolin, and
investigated its effects on the dynamics of C/EBPb and PPARc.
Similar to IBMX, forskolin raises the intracellular concentration of
cAMP, which in turn activates CREB. Therefore, the addition of
forskolin was modeled as an increase in the concentration of
IBMX relative to the unperturbed condition. As shown in
Figure 9A and Dataset S4, forskolin treatment on day 0 resulted
in 1.7-fold increase in the maximum activation of CREB as
compared to the control, while retaining the same activation
dynamics. Interestingly, the activation of C/EBPb (Figure 9B and
Dataset S4) and PPARc (Figure 9C and Dataset S4) were more
muted, increasing only 1.3-fold and 1.5-fold, respectively, com-
pared to the control condition receiving only the adipogenic
induction cocktail. These results are qualitatively consistent with
the model simulations, which also predicted an attenuation of
forskolin’s effect downstream of CREB (Figure 10). In the
simulations shown in Figure 10, the IBMX level was set to 1.4-
fold above the control condition, which resulted in the optimal fit
between the simulated profiles and experimental data. Adjusting
the IBMX level primarily affected the peak activity of CREB, and
had little effect on the C/EBPb and PPARc profiles (Figure S3).
This observation is consistent with the results of the parameter
sensitivity analysis, which showed that the rate constant for
activation of C/EBPb by CREB (k3) had little effect on any of the
model species.
Discussion
In this study, we assembled an interaction network model of
several key TFs whose concerted actions are suspected to regulate
adipocyte differentiation and lipid storage. We trained this model
using activation time profiles of the TFs measured over a nearly
three-week long period after inducing the differentiation of 3T3-
L1 preadipocytes. The activity profiles were obtained using
reporter cells generated from 3T3-L1 cells. In these reporter cell
lines, binding of a TF to its recognition sequence leads to
expression of a Gaussia luciferase reporter gene. Since the
luciferase gene has a secretion leader sequence, non-invasive
dynamic profiling of TF activity is possible by monitoring the
culture supernatant for luciferase activity. This approach enabled
us to directly monitor TF function (i.e., binding to its recognition
sequence) as opposed to inferring activity from mRNA or protein
data. The non-invasive measurement technique also allows for
frequent sampling, which, in turn, facilitates collection of data for
model construction and testing. Lastly, this approach also allows
for TF activation profiles to be measured from the same batch of
cells in a single experiment from differentiation to maturation.
The differentiation of preadipocytes into adipocytes is charac-
terized by the appearance of microscopically visible intracellular
lipid droplets and rounding of the cell shape, and is mediated by
multiple enzymes and regulatory TFs. While previous data on the
activation of different TFs underlying adipocyte differentiation
and enlargement are available in the literature, differences in the
experimental conditions and readout methods limit their utility for
developing an integrated network model. In this study, we address
this by developing a TF model using time-course data from the
same cell population.
Our results show that different TFs demonstrate distinct
activation profiles during adipocyte differentiation and enlarge-
ment, which are consistent with published reports. The temporal
correlation between CREB and C/EBPb is one such example
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(Figure 3) where activation of C/EBPb follows the activation of
CREB until day 5. Zhang and coworkers [23] showed that CREB
induces expression of C/EBPb at 8 h after induction of the
adipogenic program. Similarly, SREBP-1c has been shown to
promote adipogenesis by inducing the enzymatic production of a
PPARc ligand [14]. It has also been suggested that SREBP-1c
could transcriptionally activate PPARc by directly binding to a
PPARc promoter [16]. Another TF implicated in the regulation of
PPARc is NFAT, based on the evidence that NFAT associates
physically with PPARc [24]. Our data show that both SREBP-1c
and NFAT demonstrate activation profiles comparable to C/
EBPb, which is known to precede and activate expression of
PPARc [25], during the initial differentiation phase (days 1-3).
Thus, our data provide corroborating evidence for SREBP-1c and
NFAT in regulating PPARc activity.
Activation of PPARc is critical for terminal differentiation and
maintenance of differentiated phenotype. Our data also show that
PPARc activity increased gradually from the induction of
differentiation and stayed elevated between days 7 and 11. While
the activation levels decreased after day 11, they were still
significantly higher than pre-induction levels for the duration of
the experiment. Interestingly, only PPARc demonstrated sustained
activation as the activity of other TFs decreased to pre-induction
levels after adipocyte maturation (days 7–10). This result is
consistent with the primary role for PPARc in adipocyte
differentiation and enlargement. Interestingly, FoxO1 did not
show significant activation over the time course of the experiment.
A recent study has shown that a direct protein-protein interaction
leads to repression of PPARc activity by FoxO1 [26]. However,
since FoxO1 interferes with PPARc by recruitment to the PPARc
response element, measurement of FoxO1 binding to its own
response element may not show any correlation to alterations in
PPARc activity.
To more quantitatively characterize the dynamics of the TFs,
we assembled a mathematical model based on interactions
documented in the published literature. For four of the TFs
monitored in this study, namely CREB, C/EBPb, PPARc, and
SREBP-1c, we found a general consensus regarding the activation
cascade, with CREB and SREBP-1c upstream of C/EBPb and
PPARc, respectively, and positive feedback between C/EBPb and
PPARc. For the sake of parsimony, we modeled these interactions
as a sequence of direct activation events between TFs. The
exception was the activation of PPARc by SREBP-1c, as there was
strong evidence that SREBP-1c activation induces the production
of one or more endogenous metabolite ligands for PPARc [27].
We also explored different possibilities with regards to co-
Figure 7. Parameter distributions for the best fitting mass action model (MA31). Note that the x-axis scales have been adjusted to show
the shapes of the distributions. The distributions were obtained using a bootstrapping method by twice repeating the parameter optimization 2,000
times on noise-added data (see Materials and Methods, Parameter estimation).
doi:10.1371/journal.pone.0100177.g007
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activation requirements of a downstream TF for cases where the
TF could be activated by more than one TF and/or hormonal
input. We modeled these possibilities using a logic-based modeling
approach, which has been utilized in various forms to describe the
input-output dynamics of cellular signaling networks [28–30]. As
the TF activities varied continuously, rather than discretely, we
decided to utilize ODEs in conjunction with logical gates, similar
to the recent work by Kraeutler et al. [31]. While other
approaches such as fuzzy logic modeling could also be used to
approximate continuous variations in the model species [30], this
would require additional adjustable parameters [32] and/or
manual refinement [33], thus undermining a major benefit of
logic-based modeling, namely simplicity. Along this vein, we
compared the fits achieved using Hill equations against simpler
mass action kinetics. We found that the improvement in the SSR
achieved using Hill equations essentially reflected a larger degree
of freedom, as indicated by the adjusted R2 statistic (Table 1),
which penalizes over-fitting. Consequently, the Hill equation
models could not adequately discriminate between different logic
gate combinations based on goodness of fit. Moreover, there was
no mechanistic basis, e.g. known cooperative interactions between
the TFs modeled in this study, to support the selection of a more
complex functional form to describe the activation kinetics. For
these reasons, we focused on the first-order mass action models in
evaluating potential co-activation at various network nodes using
different logical gate combinations.
We found that an all OR-gate model best explained the data
collected in this study, although an alternative model with an AND
gate at the PPARc node fit the data nearly as well. This suggests
that PPARc activation by C/EBPb may require a ligand co-
activator, which in turn is produced by an enzyme induced by
SREBP-1c. Due to its prominent role in regulating adipogenesis
and differentiated adipocyte functions, ligand activation of PPARc
has been extensively studied using high-affinity synthetic agonists,
notably TZDs, and more recently, certain environmental chem-
icals. As a nuclear receptor, PPARc is capable of recognizing a
variety of oxidized fatty acids and related lipid metabolites,
including prostaglandins [34–36]. Tzameli and coworkers con-
structed a beta-galactosidase-based PPARc ligand-sensing vector
system to show that one or more endogenous ligands are produced
following the induction of adipogenesis in response to an elevation
in cAMP [37], but establishing the chemical identity of these
Figure 8. Simulated activity profiles for (A) CREB, (B) C/EBP, (C) PPARc, and (D) SREBP-1c generated using the best fitting mass
action model (MA31). Dashed lines show 95% confidence intervals. The confidence intervals at each time point were calculated based on the
percentiles obtained from repeated simulations using the bootstrap method (see Materials and Methods, Sensitivity analysis for details). The
measured data (normalized mean Gluc activities, RFL/h/RLU) are shown as red dots.
doi:10.1371/journal.pone.0100177.g008
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ligands has been challenging. Metabolic products of the arachid-
onate cyclooxygenase (COX) pathway, particularly 15-deoxy-
12,14 prostaglandin J2 (15-dPGJ2), have been shown to be potent
activators capable of inducing adipogenesis [38]. However, it
remains an open question as to whether differentiating adipocytes
synthesize 15-dPGJ2 or other suspected natural lipid ligands at
sufficiently high concentrations in vivo to activate 15-dPGJ2 [39].
In the present study, we did not assume a specific identity for the
natural ligand, and thus could not experimentally monitor its
concentration, which clearly contributed to the uncertainty
regarding co-activation of PPARc. In this regard, establishing
the identity of the natural ligand and tracking its concentration will
be crucial in further resolving the dynamics of the adipocyte TF
network.
As published data on adipocyte TF network activation rates
were not available, the rate parameters were estimated from the
measured profiles collected in this study. Confidence interval
calculations and parameter sensitivity analysis suggested that most
of the parameters were well constrained, and that the model
species were sensitive to the parameters, allowing the model fitting
procedure to estimate the parameters to within one order of
magnitude. Outside of the general assumption that the rate
constants have to be nonnegative, the only other constraint
applied to the parameters was to set a lower bound for the
turnover rates of the TFs. Based on the estimated parameter
distributions, the decay rate constants ranged from,0.5 day21 for
C/EBPb (k5) to ,7.2 day21 for PPARc (k8) (Table S1 and
Figure 7). These decay rate constants correspond to half-life
ranges of ,33 to ,2.3 h, which are comparable to published
turnover rates of TFs [40–45].
Compared to the other rate constants, the decay rate constant
for PPARc had a relatively large degree of uncertainty, as did two
other rate parameters for the activation or degradation of this TF.
The simplest explanation is the lack of direct and specific
experimental observations on the dynamics of the putative ligand.
The PPARc activity profile intimately depends on the ligand
profile through k11 (ligand synthesis rate constant), another
parameter with a relatively large CI length, as shown by the
sensitivity analysis (Table 2). It is likely that multiple PPARc
ligands are produced in differentiating adipocytes [46], although a
dominant endogenous ligand has not yet been conclusively
identified. Another, related limitation regarding the interpretation
of the simulated ligand time profile is that it is not possible to
determine an absolute concentration range for the ligand, because
normalized TF time profiles were used in fitting the model.
Despite these limitations, the mathematical model revealed
several noteworthy features of the adipocyte TF network. First,
model simulations of forskolin stimulation showed that an increase
in CREB activity does not propagate to C/EBP and PPARc,
indicating that the latter two TFs receive additional inputs (from
DEX and ligand) having a quantitatively larger impact than the
input from CREB. This simulation was in good agreement with
measured data, which also showed little increase in TF activity
downstream from CREB in response to forskolin treatment.
Second, the estimated values for rate parameters suggest that
feedback activation of SREBP-1c by PPARc is negligible in
comparison to activation of SREBP-1c by insulin, corroborating
the downstream placement of SREBP-1c relative to PPARc in
recently published studies [47,48]. Third, the estimated parame-
ters suggest that the strength of the positive activation loop
between C/EBP and PPARc is comparable to the strengths of the
activation cascades connecting the TFs to hormonal inputs. This
finding is consistent with previous experiments showing that direct
(e.g. genetic) manipulation of either C/EBP or PPARc could drive
the adipogensis program to similar extents as hormonal stimula-
tion [49,50].
Prospectively, the TF reporters and model described in this
study could provide a set of useful tools for investigating methods
to modulate adipocyte differentiation and metabolism by inter-
vening at the level of the regulatory network. For example, we
could simulate overall change of activity profiles for key TFs
triggered by a specific perturbation (i.e. exposure to an agonist or
antagonist) and its influence on expression levels of target genes
such as adipocyte metabolic enzymes that are regulated by the
TFs. We expect the systematic understanding of the TF network
also to lead to the development of new treatment approaches
against obesity, and for studying other phenotypes regulated by the
coordinated activity of TFs.
Figure 9. Perturbation of CREB activity profiles. (A) Perturbation
of CREB activity profiles upon addition of 10 mM of forskolin or 0.1%
DMSO at day 0 for 48 h. (B) and (C) show activation of C/EBPb and
PPARc, respectively, with forskolin treatment as compared to DMSO
control. The RLU/h/RFU for each time point was normalized to the value
at the start of differentiation (day 0). Data are from two independent
experiments and represent mean 6 SD. *: p,0.05.
doi:10.1371/journal.pone.0100177.g009
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Materials and Methods
Materials
3T3-L1 cells were kindly provided by Prof. Barbara Corkey
(Boston University School of Medicine, MA). Tissue culture
reagents including Dulbecco’s Modified Eagle’s Medium
(DMEM), calf serum (CS), fetal bovine serum (FBS), human
insulin, and penicillin/streptomycin were purchased from Invitro-
gen (Carlsbad, CA). Unless otherwise noted, all other chemicals
were purchased from Sigma (St. Louis, MO).
Cell culture and differentiation
3T3-L1 cells were seeded in 6-well tissue culture plates in
preadipocyte growth medium consisting of DMEM supplemented
with CS (10% v/v), penicillin (200 U/ml) and streptomycin
(200 mg/ml). Medium was replenished every other day. Two days
post-confluence, differentiation was induced using a standard
adipogenic cocktail (1 mg/ml insulin, 0.5 mM isobutylmethyl-
xanthine, and 1 mM dexamethasone) added to a basal medium
(DMEM with 10% FBS and penicillin/streptomycin). After 48 h,
the first differentiation medium was replaced with a second
differentiation medium consisting of the basal adipocyte medium
supplemented with only (1 mg/ml) insulin. After another 48 h, the
second medium was replaced with the adipocyte basal medium
and replenished every other day.
Construction of Gaussia luciferase (Gluc) reporter
plasmids
Lentiviral reporter plasmids for monitoring activation of six
transcription factors (TFs) - PPARc, SREBP-1c, NFAT, CREB,
C/EBPb and FoxO1 - during adipocyte differentiation and lipid
loading were constructed as described below. For each TF,
consensus binding sites (response elements; RE) in target gene
promoter regions were identified using TRANSFAC database 7.0
Public (AGGACAAAGGTCA for PPARc, CATGTG for
SREBP-1c, GGAAAATTTGAGTCA for NFAT, TGACGTCA
for CREB, ATTGCGCAAT for C/EBPb and AGTTGGACGC-
GAC for FoxO1). Response element (RE) oligonucleotides
containing the binding sequence for each TF were chemically
synthesized. Each RE oligonucleotide consists of three consensus
binding sequences separated by 4–6 bases (spacer sequence) and a
unique restriction enzyme (EcoRI and AfeI) cleavage sites at the
Figure 10. Simulated activity profiles for (A) CREB, (B) C/EBP, and (C) PPARc generated using the best fitting mass action model
with added forskolin input. Forskolin treatment was modeled as a step increase in IBMX during the first induction period (days 0 to 2). All other
model parameters (k1–k13) were kept at the same values that were estimated from the training data without forskolin. Dashed lines show 95%
confidence intervals. The measured data (normalized mean Gluc activities, RFL/h/RLU) are shown as red dots.
doi:10.1371/journal.pone.0100177.g010
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ends. The RE oligonucleotides were cloned into Gluc-DRE2-viral
vector (pCS-sMAR8-pA1-DRE2-hPGK-cHS4-tACTB-SPA-
Gluc-CMVmin) [51] in which expression of the Gaussia luciferase
(Gluc) is under the control of a minimal promoter. Expression of
Gluc is induced only when a TF binds to its consensus binding site.
In addition, a plasmid containing a non-specific binding sequence
(AGTTGGACGCGAC) was constructed to generate a control cell
line that expresses a basal level of Gluc in a TF independent
manner. Clones containing the correct RE were identified by
multiple restriction enzyme digests and sequenced to verify fidelity.
Generation of stable reporter cell lines
Stable reporter cell lines for each TF were generated by
lentiviral transduction. To produce lentiviral particles, each TF
reporter plasmid and two helper plasmids (psPAX; Addgene
plasmid 12260 and pMD2.G; Addgene plasmid 12259, Dr.
Trono, Lausanne, Switzerland) were co-transfected into 293T/
17 cells using the calcium phosphate transfection method [52].
After 24 h following the transfection, the medium was replenished
and 5 mM of sodium butyrate was added, and incubated for an
additional 24 h. Supernatants containing viral particles were
collected, pooled, filtered with 0.45 mm filters, and centrifuged for
2 h at 4uC at 480006g. The viral titer was measured using a
Lenti-X qRT-PCR titration kit (Clontech, Palo Alto, CA). To
transduce 3T3-L1 preadipocytes, concentrated virus particles
(,26108 IFU) were added to the cells in presence of Polybrene
(hexadimethrine bromide). The cells were incubated with the virus
particles for 15 h, and the medium was replenished the next day.
The efficiency of transduction was assessed by microscopic
analysis.
Validation of reporter plasmid function
Plasmids for constitutive expression of the TFs were purchased
from Addgene (pCMV5-FLAG-FoxO1, pSV Sport SREBP-1c,
pEGFP-C1 NFAT3, pcDNA flag PPAR gamma) or Invitrogen
(pCMV-Sport6-CREB). 293T/17 cells were seeded in 6-well tissue
culture plates, and ,1 mg of each expression plasmid was
cotransfected along with the corresponding reporter plasmid
(,1 mg) using the calcium phosphate transfection. For control
experiments, the same amount of pEYFP-N1 plasmid (constitutive
expression of yellow fluorescent protein) was transfected. At 48 h
post-transfection, supernatants were collected and luciferase
activity measured using the BioLux Gaussia Luciferase Flex assay
kit (New England Biolabs, Ipswich, MA). Additionally, the PPARc
reporter plasmid was validated using thiazolidinedione (TZD) as
the agonist. PPARc was overexpressed from plasmid (pcDNA flag
PPAR gamma) in 3T3-L1 PPARc reporter cells and 25 mM TZD
was used to activate PPARc for 24 h. The C/EBPb reporter cell
line was validated by up-regulating C/EBPb with 100 ng/mL
oncostatin M (OSM) for 12 h [53]. Luciferase activity in the
supernatant was determined as described above.
Measurement of transcription factor activity profiles
For profiling TF activation in each reporter cell line, 3T3-L1
preadipocyte reporter cells for each TF were seeded in 6-well
tissue culture plates and differentiated into adipocytes as described
above. At different stages post-differentiation, 30 mL supernatant
samples were collected at 24 h post-medium change from day 0
(induction of differentiation) until day 17. Samples were stored at
220uC prior to assessing luciferase activity. The luciferase activity
(Relative Light Units; RLU) measured was used to calculate the
rate of Gluc production (RLU divided by the time over which
Gluc was secreted). As the red fluorescence intensity (Relative
Fluorescence Units; RFU) measured at 550 nm (excitation) and
600 nm (emission) scales linearly with cell density (Figure S4A) and
the Gluc activity (RLU) also correlates with RFU (Figure S4B), the
rate of Gluc production was also normalized with the RFU to
account for differences in cell density between different experi-
ments. The fold-increase in TF activity was determined by
normalizing the (RLU/h)/RFU at each time point to the
corresponding value at the start of differentiation (i.e., day 0).
Perturbation of the transcription factor network by
forskolin
CREB, C/EBPb and PPARc reporter cell lines were seeded in
6-well tissue culture plates and differentiated into adipocytes as
described above. Cells were treated with 10 mM of forskolin or
0.1% DMSO starting at day 0 for 48 h. TF-driven luciferase
activity in the supernatants was determined and the TF activation
profiles were determined as described above.
Transcription factor network
An interaction network model of the TFs analyzed in this study
was assembled based on activation relationships between the TFs
documented in the published literature [11,16,18,23,24,50,54–
56]. A schematic of the model is shown in Figure 4. The model
included only four out of the six measured TFs, i.e. CREB, C/
EBPb, PPARc, and SREBP-1c, as interactions involving NFAT
and FoxO1 were not consistently documented in the literature.
The guiding principle in assembling the model was simplicity.
While it is likely that some of the TFs interact with each other
through intermediaries and co-activators, these molecules were not
experimentally monitored in this study, and thus it was not
attempted to model these details. Including additional details
could potentially improve the fit of the model to the data, but also
carried the risk of over-fitting the measured data. For this reason,
the activation of a TF by another factor was assumed to occur
directly. The exception was the activation of PPARc by SREBP-
1c, which was assumed to involve the induction of a metabolic
enzyme leading to the production of an activating ligand for
PPARc. A number of candidate ligands have been proposed such
as 13-hydroxyoctadecadienoic acid, 15-hydroxyeicosatetraenoic
acid and 1-O-hexadecyl-2-Azelaoyl-sn-glycero-3-phosphocholine
[57,58]. While the identity of this ligand remains to be definitively
established, there is reasonable consensus that SREBP-1c activa-
tion of PPARc involves the endogenous production of a metabolite
ligand.
Including the putative PPARc ligand, the TF network model
comprises 5 species whose levels varied continuously with time. In
addition, the model included three input species representing the
differentiation inducing hormones insulin, dexamethasone (DEX),
and isobutylmethylxanthine (IBMX). The levels of these input
species were set to one (arbitrary units) or zero to reflect the
addition and withdrawal of the hormones at different stages of a
differentiation experiment. For the initial induction period from
time zero to 48 h, the levels of all three input species were set to
one. For the second induction period from 48 h to 96 h, DEX and
IBMX were set to zero, while insulin was kept at one. For the
maintenance period from 96 h to end of the experiment, all input
species were set to zero.
The rates of change of the 5 time variant species were described
using ordinary differential equations (ODEs). Partial differentia-
tion equations or stochastic equations were not considered,
because the data collected reflected the pooled averages of many
(.106) cells in a well-mixed environment. Two types of ODE
models were created: first-order mass action kinetic models and
Hill equation models. Mass action models offer the benefit of
parsimony, while Hill equation models could be appropriate for
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networks exhibiting sigmoidal output responses to inputs [31]. By
default, the ODE models implicitly assume that inputs to a node in
the network are independent and additive. However, it is possible
that for some TFs, multiple inputs are simultaneously required to
result in activation. To explore this possibility, we utilized logical
AND/OR gates to model the activation of TFs that received
multiple inputs. We used an AND gate to represent the scenario
where activation of a TF cannot occur unless all inputs are non-
zero. Mathematically, the AND gate was represented by the
minimum of all possible inputs to express the dependence of TF
activation on the limiting species. We used an OR gate to model
the alternative scenario where each input independently contrib-
utes to TF activation. This was mathematically represented by the
sum of all inputs. The general structure of the ODEs for the mass
action kinetic models was as follows.
Mass Action (OR Gate):
dyi
dt
~
X
j
kjwiyj{kdyi ð1Þ
Mass Action (AND Gate):
dyi
dt
~min(kjwiyj){kdyi ð2Þ
In equations (1) and (2), yi is the amount of active TF i, yj is the
amount of a TF j that activates i, and kj.i is the rate constant for
first-order activation of i by j. Every TF was assumed to decay at a
rate proportional to its amount with a first-order degradation rate
constant kd. The rate of production and degradation of the
metabolite ligand was modeled similarly using first-order rate
expressions.
The general structure of the ODEs describing the TF dynamics
for the Hill equation models was as follows:
Hill Equation (OR Gate):
dyi
dt
~
X
j
bjwiy
njwi
j
K
njwi
jwizy
njwi
j
{kdyi ð3Þ
Hill Equation (AND Gate):
dyi
dt
~min
bjwiy
njwi
j
K
njwi
jwizy
njwi
j
 !
{kdyi ð4Þ
In equations (3) and (4), yi, yj, and kd have the same meaning as
described above for the mass action kinetic models. The parameter
nj.i is the Hill coefficient for the activation of i by j, which is a
measure of cooperativity between substrate binding events leading
to activation. The parameter Kj.i is the Hill constant for the
activation of i by j, and corresponds to the substrate concentration
that results in half-maximal response, and bj.i is a rate constant
analogous to the mass action rate constant kj.i.
Three of the TF species in the model received more than one
input. These were C/EBPb, PPARc, and SREBP-1c. Since
molecular level details needed to determine the input requirements
were not available, all possible combinations of logic gates were
tested. Each mass action or Hill equation model had the same
respective governing equations for the CREB and ligand nodes
(since these received only one input each), but included a different
combination of logic gates at the C/EBPb, PPARc, and SREBP-
1c nodes. The possible logic gates at the C/EBPb, PPARc, and
SREBP-1c nodes are shown in Table S3. The combinations of
logic gates resulting in different model structures are shown in
Table S4. The 32 gate combinations shown in Table S4 were each
modeled with both mass action kinetics and Hill equations,
resulting in a total of 64 distinct model variants. The full set of
ODEs describing mass action Model 31 and Hill equation Model
31 (all OR combinations) are shown in Tables S1 and S2,
respectively.
Parameter estimation
The model parameters (Tables S1 and S2) were estimated from
the experimentally obtained TF time course data (control
condition without forskolin treatment) using a nonlinear con-
strained optimization procedure. The objective function was to
minimize the sum of squared residuals (SSR) measuring the
discrepancy between the measured and calculated transcription
factor levels for all time points.
min
X
t
X
i
y
exp
i,y {y
model
i,t
 2
ð5Þ
In the above expression, yi,t refers to the ith TF activity level (in
RLU/h/RFU) at time point t, with the superscript denoting
experimentally measured or model calculated value. The optimi-
zation variables were the model parameters. The total number of
parameters in each mass action or Hill equation model was 13 or
31, respectively. The experimental data were averages of two
independent experiments, where each experiment included two
biological replicates for each TF. Parameter optimization was
iterated 50 times. Each time, randomly generated noise drawn
from a normal distribution was added to the experimental data. A
noise level of 5% standard deviation was used based on average
variances in the measured TF activities across replicate experi-
ments. For each of the 50 iterations, the optimization was repeated
5 times using a randomly generated set of initial parameter values.
For the mass action models, the upper bounds on the
parameters were set to 100 (day21) to ensure that the first-order
rate parameters are of similar magnitude as the observed rates,
which were on the order of ,100 day21 (due to normalization of
the experimental data). The lower bounds on the TF degradation
rate constants (k2, k5, k8 and k10) were set to 0.5, to ensure that
there is a finite degradation rate for each of the factors. We chose a
minimal rate constant value that is equivalent to a half-life of ca.
36 h, which is 5- to 10-fold longer than the reported half-lives of
TF modeled in this study. The lower bounds on all other
parameters were set to zero. The initial values of the TFs were set
to one (‘1’) to reflect the normalization of the experimental data.
The initial value of the metabolite ligand was set to zero, as it was
assumed that the ligand is not present in preadipocytes prior to
induction.
The bounds for the Hill equation model parameters were set
identically, with the exception of the Hill coefficients (Table S2,
parameters 14 through 22). These coefficients were constrained by
an upper bound of 40 based on the rationale that Hill coefficient
values should in principle reflect the number of total ligand
binding sites on a macromolecule. The values reported in the
literature are generally on the order of 100 [31,32,59]. The
parameter optimization was performed using the LSQNONLIN
function (trust-region-reflective method) of the Optimization
Toolbox in MATLAB (Natick, MA).
Simulation of the transcription factor network
The TF network model described above was evaluated by
comparing the simulated TF time profiles against experimental
data. Model simulations were performed using all 50 sets of
parameters, leading to 50 different sets of TF time profiles for each
of the 64 model variants. Addition of forskolin, which rapidly
increases intracellular cAMP [60], was modeled as step increase in
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IBMX during the first induction period (time 0 to 48 h) from a
value of 1 to 1.3. This step increase in IBMX was set based on the
measured profile of CREB, which is the direct target of IBMX in
the model. All other model parameters and initial values were the
same as the parameter estimation problem.
Sensitivity analysis and confidence interval calculation
The sensitivity of the model simulations to the estimated
parameter values was analyzed using a bootstrapping method [61].
The sensitivity analysis was performed only for the best fitting mass
action model (MA31). To generate the bootstrap data, the
experimental data was resampled by adding random noise drawn
from a normal distribution, similar to the procedure used for
parameter estimation. First, parameter optimization was per-
formed as described above on 2,000 bootstrap datasets to generate
2,000 corresponding parameter sets, which were then used to
determine the confidence intervals (CIs). The 95% CI for each
parameter was found by the percentile method:
plo,pup
 
~ p^a=2,p^1{a=2
 
ð6Þ
In equation (6), plo and pup are the lower and upper confidence
limits, respectively, and p^a=2 and p^1{a=2 refer to the 2.5th and
97.5th percentiles of the dataset. Next, 2,000 new bootstrap data
sets were generated using the resampling method. The new
resampled data were then used to re-estimate the model
parameters. For this re-estimation, the lower and upper bounds
for the parameters were set based on the 95% CI values
determined previously. The new set of parameters was then
filtered for outliers as follows. For each parameter, the spread (sp)
was defined as the interquartile range (Q3–Q1). Outliers were
defined as parameter values that were less than Q121.5sp or
greater than Q3+1.5sp. After removing the outliers, new CIs for
the parameters were calculated from their distributions (number
density functions). The length (L) and shape (sh) of the CIs were
calculated as follows:
L~plo{pup ð7Þ
sh~
pup{p
p{plo
ð8Þ
In equations (7) and (8), plo and pup are the lower and upper
parameter confidence limits, respectively, and p is the mean value
of the parameter p. Larger lengths indicate less sensitivity to a
given parameter, and shape values greater than 1.0 indicate
nonlinearity of the model with respect to the parameters. The 95%
CIs of the state variables were estimated from the TF and ligand
time profiles simulated using the bootstrap parameters.
Using the bootstrap datasets that do not contain outliers as the
baseline, numerical perturbation experiments were performed to
quantify the change in model species (TFs and ligand) resulting
from a finite change in a single parameter. Each experiment
increased or decreased the value of a single parameter by a fixed
fraction (e.g. 15%), while keeping all other parameters constant.
The corresponding changes in the TF and ligand time profiles
were calculated as follows:
DYi,j~
X
t
Yi,j,t{Y

i,t
 
ð9Þ
In equation (9), Y*i,t is the activity of species i at time calculated
using an unperturbed set of parameters, and Yi,j,t is the
corresponding activity after parameter j has been perturbed. A
one-sample t-test (p,0.05) was performed on the resulting sum of
changes DY to determine whether the perturbation had a
significant, non-zero effect. As every parameter significantly
affected at least one model species, we also determined how far
the perturbed profiles deviated from the unperturbed profiles by
averaging the distribution of activity profiles for each combination
of model species and parameter perturbation. The differences
between the perturbed and unperturbed profiles were quantified
by computing the fraction of points in the perturbed profiles that
lie outside the 95% confidence intervals of the corresponding
unperturbed profile.
Supporting Information
Figure S1 3T3-L1 transcription factor reporter cells after 19
days of induction for differentiation. Transmitted light images of
(A) FoxO1, (C) CREB, (E) NFAT, (G) SREBP-1c and (I) C/EBPb
and red fluorescence images of (B) FoxO1, (D) CREB, (F) NFAT,
(H) SREBP-1c and (J) C/EBPb. Scale bar = 50 mm. Figure S1.
3T3-L1 transcription factor reporter cells after 19 days of
induction for differentiation. Transmitted light images of (A)
FoxO1, (C) CREB, (E) NFAT, (G) SREBP-1c and (I) C/EBPb and
red fluorescence images of (B) FoxO1, (D) CREB, (F) NFAT, (H)
SREBP-1c and (J) C/EBPb. Scale bar = 50 mm.
(TIF)
Figure S2 Comparison of residuals calculated for Hill equation
and mass action models. The model numbers refer to different
combination of logic gates at C/EBP, PPARc, and SREBP-1c.
The specific combination of gates for each model number can be
determined from Tables S3 and S4. Data shown are the best
(lowest) SSR for each model variant calculated from 50 repeated
optimization runs (see Materials and Methods, Parameter
optimization for additional details).
(TIFF)
Figure S3 Effect of IBMX input concentration on model
simulation. Data shown are plots of (A) CREB, (B) C/EBP, and
(C) PPARc activity time profiles generated using the best fitting
mass action model (MA31) with different IBMX concentrations for
the initial induction period. The optimal IBMX input resulting in
the best fit of the model to the forskolin data was determined to be
1.4 (i.e. a 40% increase over the induction experiment without
forskolin). This was determined by optimizing on the IBMX input
level using the TF data from the forskolin experiment, with all
other parameters set to the best fit values from the training data
without forskolin. Varying the IBMX concentration from 1.0 (i.e.
without forskolin added) to 1.7 had no significant impact on the
profiles for C/EBP and PPARc. The input IBMX levels used for
the different activity profiles are specified in the figure legend.
(TIFF)
Figure S4 Relationship between cell number, red fluorescence
intensity, and luciferase activity. (A) Different numbers of 3T3-L1
FoxO1 reporter cells were seeded in a 24-well plate and red
fluorescence intensity (RFU) was measured at 550 nm (excitation)
and 600 nm (emission) after 6 h. (B) A 3T3-L1 cell line with a non-
specific transcription factor binding site (AGTTGGACGCGAC)
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was generated as described in Materials and Methods. Cells were
seeded at different numbers in a 24-well plate and the luciferase
activity in the supernatant determined after 24 h along with
measurement of RFU in the cells.
(TIF)
Table S1 Mass action model equations and parameters. The
parameter values correspond to the best fitting mass action model
(MA31), which has OR gates at every node in the TF network.
(DOCX)
Table S2 Hill equation model equations and parameters. The
parameter values correspond to the best fitting Hill equation
model (HE31), which has OR gates at every node in the TF
network.
(DOCX)
Table S3 Possible logic gate combinations at C/EBP, PPARc,
and SREBP-1c.
(DOCX)
Table S4 Model variants representing different logic gate
combinations. Each model row corresponds to a specific model
variant. Each model variant, two types of ODE models were
implemented, mass action and Hill equation, resulting in a total of
64 model variant-ODE combinations.
(DOCX)
Dataset S1 Fold change (RLU/h/RFU) in the activation of
different TF during adipocyte differentiation and maintenance.
RLU/h/RFU values were determined by normalizing the RLU/
h/RFU at each time point to the corresponding value at the start
of differentiation (i.e., day 0). Data are from two independent
experiments and represent mean 6 SD. *: p,0.05.
(XLSX)
Dataset S2 Effect of parameter perturbations on calculated
model species. The perturbed parameters refer to the besting
fitting mass action model (MA31), with the parameters indicated
by their numbers (in rows). Each block of columns describes the
effect of a 15% increase or decrease on the change on a particular
model species, as calculated by equation (9). The mean change in
model species, standard deviation, and the CIs are shown in the
corresponding columns. The t-test column shows the results of a
one-sample t-test performed on the sum of changes in the model
species. A value of 1 in the t-test column indicates that the sum of
changes in the model species resulting from the parameter
perturbation was significantly different from zero (p,0.05). See
Methods for additional details.
(XLSX)
Dataset S3 Fraction of calculated model species values that lie
outside of the 95% CI bounds of the unperturbed baseline case
after the indicated parameter has been perturbed. The perturbed
parameters refer to the besting fitting mass action model (MA31),
with the parameters indicated by their numbers (in rows). Each
block of columns describes the results of a different level of
perturbation (ranging from +/225 to +/275%). Each column in
the block describes the results for a different model species, as
identified by the heading. For a given time point in the
numerically integrated time profile, whether a perturbed species
value lies outside of the CI bounds was determined based on the
mean of the bootstrap values. Each calculated model species
profile comprised 88 discrete, equally spaced integration time
steps.
(XLSX)
Dataset S4 Fold change (RLU/h/RFU) in the activation
CREB, C/EBP and PPARc upon addition of 10 mM of forskolin
or 0.1% DMSO at day 0 for 48 h. RLU/h/RFU values were
determined by normalizing the RLU/h/RFU at each time point
to the corresponding value at the start of differentiation (i.e., day
0). Data are from two independent experiments and represent
mean 6 SD. *: p,0.05.
(XLSX)
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